Literature DB >> 24850787

Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase.

Rita Meleddu1, Valeria Cannas, Simona Distinto, Giorgia Sarais, Claudia Del Vecchio, Francesca Esposito, Giulia Bianco, Angela Corona, Filippo Cottiglia, Stefano Alcaro, Cristina Parolin, Anna Artese, Daniela Scalise, Massimo Fresta, Antonella Arridu, Francesco Ortuso, Elias Maccioni, Enzo Tramontano.   

Abstract

A small library of 1,3-diarylpropenones was designed and synthesized as dual inhibitors of both HIV-1 reverse transcriptase (RT) DNA polymerase (DP) and ribonuclease H (RNase H) associated functions. Compounds were assayed on these enzyme activities, which highlighted dual inhibition properties in the low-micromolar range. Interestingly, mutations in the non-nucleoside RT inhibitor binding pocket strongly affected RNase H inhibition by the propenone derivatives without decreasing their capacity to inhibit DP activity, which suggests long-range RT structural effects. Biochemical and computational studies indicated that the propenone derivatives bind two different interdependent allosteric pockets.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV-1; RNase H; antiviral agents; dual inhibitors; enzymes; molecular modeling

Mesh:

Substances:

Year:  2014        PMID: 24850787     DOI: 10.1002/cmdc.201402015

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  11 in total

1.  Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.

Authors:  Tetsuro Hisayoshi; Mayu Shinomura; Kanta Yokokawa; Ikumi Kuze; Atsushi Konishi; Kumi Kawaji; Eiichi N Kodama; Keishi Hata; Saori Takahashi; Satoru Nirasawa; Shohei Sakuda; Kiyoshi Yasukawa
Journal:  J Nat Med       Date:  2015-02-08       Impact factor: 2.343

2.  Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.

Authors:  Angela Corona; Francesco Saverio Di Leva; Sylvain Thierry; Luca Pescatori; Giuliana Cuzzucoli Crucitti; Frederic Subra; Olivier Delelis; Francesca Esposito; Giuseppe Rigogliuso; Roberta Costi; Sandro Cosconati; Ettore Novellino; Roberto Di Santo; Enzo Tramontano
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

3.  Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.

Authors:  Angela Corona; Valentina Onnis; Alessandro Deplano; Giulia Bianco; Monica Demurtas; Simona Distinto; Yung-Chi Cheng; Stefano Alcaro; Francesca Esposito; Enzo Tramontano
Journal:  Pathog Dis       Date:  2017-08-31       Impact factor: 3.166

4.  Structure-guided approach identifies a novel class of HIV-1 ribonuclease H inhibitors: binding mode insights through magnesium complexation and site-directed mutagenesis studies.

Authors:  Vasanthanathan Poongavanam; Angela Corona; Casper Steinmann; Luigi Scipione; Nicole Grandi; Fabiana Pandolfi; Roberto Di Santo; Roberta Costi; Francesca Esposito; Enzo Tramontano; Jacob Kongsted
Journal:  Medchemcomm       Date:  2018-02-01       Impact factor: 3.597

5.  Chelation Motifs Affecting Metal-dependent Viral Enzymes: N'-acylhydrazone Ligands as Dual Target Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain.

Authors:  Mauro Carcelli; Dominga Rogolino; Anna Gatti; Nicolino Pala; Angela Corona; Alessia Caredda; Enzo Tramontano; Christophe Pannecouque; Lieve Naesens; Francesca Esposito
Journal:  Front Microbiol       Date:  2017-03-20       Impact factor: 5.640

6.  Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.

Authors:  Rita Meleddu; Simona Distinto; Angela Corona; Enzo Tramontano; Giulia Bianco; Claudia Melis; Filippo Cottiglia; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

Review 7.  Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.

Authors:  Lucianna Helene Santos; Rafaela Salgado Ferreira; Ernesto Raúl Caffarena
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11       Impact factor: 2.743

8.  Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.

Authors:  Angela Corona; Rita Meleddu; Francesca Esposito; Simona Distinto; Giulia Bianco; Takashi Masaoka; Elias Maccioni; Luis Menéndez-Arias; Stefano Alcaro; Stuart F J Le Grice; Enzo Tramontano
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

9.  Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication.

Authors:  Cinzia Sanna; Monica Scognamiglio; Antonio Fiorentino; Angela Corona; Vittoria Graziani; Alessia Caredda; Pierluigi Cortis; Mariofilippo Montisci; Elisa Rita Ceresola; Filippo Canducci; Ferruccio Poli; Enzo Tramontano; Francesca Esposito
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

10.  2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.

Authors:  Angela Corona; Valentina Onnis; Claudia Del Vecchio; Francesca Esposito; Yung-Chi Cheng; Enzo Tramontano
Journal:  Molecules       Date:  2020-03-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.